News and Position Papers
News
21.01.2026
EFCG welcomes the European Parliament’s Commitment to a Strong Critical Medicines Act
The European Fine Chemicals Group (EFCG) welcomes the European Parliament’s position on the Critical Medicines Act (CMA), a landmark initiative…
18.12.2025
The Strategic Role of CDMOs in Europe’s Biopharmaceuticals future
EFCG calls on policymakers to decisively imbed Contract Development and Manufacturing Organizations (CDMOs) within the Biotech Act’s implementation roadmap. This…
14.03.2023
Article in Chemistry Today – Chimica Oggi
In the past three years, EFCG relentlessly strove to alert EU authorities on the need to address head-on the root…
09.11.2022
A strong European API Industry can achieve strategic autonomy of the EU Health System
Europe needs a strong EU-based API industry to achieve strategic autonomy for its health system. The COVID-19 pandemic highlighted the…
23.08.2022
Register now to the CPhI webinar on excipients
The CPhI is organising a – free – webinar on Why the Excipients Market Needs to Embrace the New Normal.…
13.01.2022
Register to the CPhI webinar on 26th January
Our EFCG Vice-President Gildas Barreyre (General Secretary, SEQENS) and Dirkjan van Zoelen (Manager Development and Technical Support, Aspen Oss B.V),…
23.11.2021
EFCG – MfE Press Release
The EU must stop the offshoring of essential medicines manufacturing investments: ambitious, open and coherent policies must support competitive, robust…
29.10.2021
SICOS press release – Health industries propose concrete measures to secure the supply chain of medicines
For a proactive industrial policy for the pharmaceutical industry to guarantee sustainable safety and health autonomy: on the basis of…
31.08.2021
Register to our Crop Protection & Fine Chemicals Forum webinar on 28 September
To know more about the future drivers of the agrochemicals business or about the impact of the EU Green Deal…
Position Papers
Position paper 22.05.2026
EFCG Position Paper on the Global Health Resilience Initiative
EFCG, the European Fine Chemicals Group representing the European manufacturers of fine chemicals including Active Pharmaceutical Ingredients (APIs), excipients and intermediates, welcomes the…
Position paper 19.05.2026
Strengthening Europe’s Health Biomanufacturing Value Chains with the Biotech Act I – May 2026
The European Fine Chemicals Group (EFCG), a sector group of Cefic representing the European manufacturers of fine chemicals including Active…
Position paper 13.05.2026
EFCG Position Paper on the provisional agreement on the CMA
The European Fine Chemicals Group (EFCG) welcomes the provisional agreement reached between the European Council and the European Parliament on the Critical…
Position paper 19.11.2025
Call for Action – Critical Medicines Act
Europe faces a pivotal moment in its ability to provide essential medicines to its citizens. The Critical Medicines Act (CMA)…
Position paper 09.11.2022
A strong European API Industry can achieve strategic autonomy of the EU Health System
Europe needs a strong EU-based API industry to achieve strategic autonomy for its health system. The COVID-19 pandemic highlighted the…
Position paper 18.03.2020
Addressing the acute and complex issue of medicines shortages
Medicines shortages are increasingly becoming an acute issue, putting undue strain on healthcare professionals and endangering the well-being and life…
